Optimal contemporary management of symptomatic and asymptomatic carotid artery stenosis
Kosmas I Paraskevas1, Dimitri P Mikhailidis, Wesley S Moore
1Department of Vascular Surgery, Red Cross Hospital, Athens 14122, Greece.
Insights
Optimal management for carotid artery stenosis involves carotid endarterectomy (CEA) for most symptomatic patients. Asymptomatic patients should receive best medical treatment (BMT), with select high-risk individuals considered for invasive procedures.
Area of Science:
- Vascular Surgery
- Neurology
- Cardiology
Background:
- Carotid artery stenosis poses a significant stroke risk.
- Optimal management strategies for both symptomatic and asymptomatic stenosis require clarification.
Purpose of the Study:
- To outline current best practices for managing carotid artery stenosis.
- To differentiate treatment approaches for symptomatic versus asymptomatic cases.
Main Methods:
- Review of current clinical data and guidelines.
- Discussion of risk stratification models for asymptomatic patients.
Main Results:
- Carotid endarterectomy (CEA) is recommended for most symptomatic carotid artery stenosis.
- Carotid artery stenting (CAS) is reserved for symptomatic patients unsuitable for CEA.
- Best medical treatment (BMT) is the primary approach for asymptomatic patients.
Conclusions:
- Symptomatic stenosis management prioritizes CEA, with CAS as an alternative for specific contraindications.
- Asymptomatic stenosis management focuses on BMT, with potential consideration for invasive procedures in identified high-risk subgroups.
- Further research is needed to precisely identify asymptomatic individuals who would benefit from invasive intervention.
Abstract:
This commentary addresses the issue of optimal contemporary management of symptomatic and asymptomatic carotid artery stenosis. Based on current data, carotid endarterectomy (CEA) should be performed in the majority of patients with symptomatic carotid artery stenosis. Carotid artery stenting (CAS) should be reserved for a minority of these symptomatic patients, in whom CEA is contraindicated. In asymptomatic patients, all should be placed on best medical treatment (BMT). With the use of one or more of the proposed stroke risk stratification models or some as yet undetermined method, the identification of those asymptomatic individuals may be possible in whom stroke risk is higher than usual with BMT. This asymptomatic subgroup, which may be small and is yet to be determined with certainty, could be offered an invasive carotid procedure (either CAS or CEA).
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Angina IV: Management
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis IV: Nursing Management

